NO933423L - Modifisert blodplate-faktor-4 - Google Patents

Modifisert blodplate-faktor-4

Info

Publication number
NO933423L
NO933423L NO933423A NO933423A NO933423L NO 933423 L NO933423 L NO 933423L NO 933423 A NO933423 A NO 933423A NO 933423 A NO933423 A NO 933423A NO 933423 L NO933423 L NO 933423L
Authority
NO
Norway
Prior art keywords
platelet factor
mpf
cpf
modified platelet
factor
Prior art date
Application number
NO933423A
Other languages
English (en)
Norwegian (no)
Other versions
NO933423D0 (no
Inventor
Shalley Kant Gupta
Jai Pal Singh
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO933423D0 publication Critical patent/NO933423D0/no
Publication of NO933423L publication Critical patent/NO933423L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO933423A 1992-09-25 1993-09-24 Modifisert blodplate-faktor-4 NO933423L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95279792A 1992-09-25 1992-09-25

Publications (2)

Publication Number Publication Date
NO933423D0 NO933423D0 (no) 1993-09-24
NO933423L true NO933423L (no) 1994-03-28

Family

ID=25493243

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933423A NO933423L (no) 1992-09-25 1993-09-24 Modifisert blodplate-faktor-4

Country Status (24)

Country Link
US (3) US5538949A (ja)
EP (1) EP0589719B1 (ja)
JP (1) JPH06220091A (ja)
KR (1) KR940007059A (ja)
CN (1) CN1035257C (ja)
AT (1) ATE151777T1 (ja)
AU (1) AU665114B2 (ja)
BR (1) BR9303903A (ja)
CA (1) CA2106629A1 (ja)
CZ (1) CZ195193A3 (ja)
DE (1) DE69309827T2 (ja)
DK (1) DK0589719T3 (ja)
ES (1) ES2101237T3 (ja)
FI (1) FI934183A7 (ja)
GR (1) GR3023356T3 (ja)
HK (1) HK100597A (ja)
HU (1) HUT69928A (ja)
IL (1) IL107040A0 (ja)
MX (1) MX9305901A (ja)
MY (1) MY109158A (ja)
NO (1) NO933423L (ja)
NZ (1) NZ248724A (ja)
YU (1) YU61893A (ja)
ZA (1) ZA936925B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4
IL113561A0 (en) * 1994-05-09 1995-08-31 Lilly Co Eli Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
US5994292A (en) * 1995-05-31 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Interferon-inducible protein 10 is a potent inhibitor of angiogenesis
JPH09143199A (ja) * 1995-11-17 1997-06-03 Nippon Chem Res Kk 血小板第４因子の製造方法
CN101307106B (zh) * 1995-12-13 2013-06-12 儿童医学中心公司 内皮细胞增殖抑制剂及其应用方法
FR2774990B1 (fr) * 1998-02-16 2000-07-28 Inst Vaisseaux Et Du Sang Nouveaux peptides, utilisation en therapeutique et compositions pharmaceutiques les renfermant
CZ307433B6 (cs) 2001-09-12 2018-08-22 Leadiant Biosciences Sa Deriváty částečně desulfátovaných glykosaminoglykanů jako inhibitory heparanázy mající antiangiogenní účinky a zabraňující antikoagulačnímu působení
EP1812468A2 (en) * 2004-09-15 2007-08-01 K.U.Leuven Research & Development Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis
CN114805536B (zh) * 2022-06-24 2022-09-02 北京百臻生物技术有限公司 一种人血小板因子4蛋白突变体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737580A (en) * 1985-03-15 1988-04-12 Oncogen Platelet related growth regulator
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
US5086164A (en) * 1989-01-10 1992-02-04 Repligen Corporation Novel methods and compositions for treatment of angiogenic diseases
US5187075A (en) * 1989-01-26 1993-02-16 Sri International Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses
US5112946A (en) * 1989-07-06 1992-05-12 Repligen Corporation Modified pf4 compositions and methods of use
EP0423641A3 (en) * 1989-10-18 1992-01-15 Nippon Mining Company Limited Expression vector, transformed microorganism, fusion protein and method for the production of platelet factor 4 or tgfalpha
JPH06504262A (ja) * 1990-07-27 1994-05-19 レブリゲン　コーポレーション 脈管形成性の病気の処置用の新規な方法と組成物
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4

Also Published As

Publication number Publication date
NZ248724A (en) 1995-10-26
NO933423D0 (no) 1993-09-24
IL107040A0 (en) 1993-12-28
DE69309827T2 (de) 1997-08-28
HK100597A (en) 1997-08-08
ES2101237T3 (es) 1997-07-01
CA2106629A1 (en) 1994-03-26
EP0589719B1 (en) 1997-04-16
YU61893A (sh) 1996-02-19
DE69309827D1 (de) 1997-05-22
HU9302687D0 (en) 1993-12-28
JPH06220091A (ja) 1994-08-09
FI934183L (fi) 1994-03-26
BR9303903A (pt) 1994-06-14
CN1035257C (zh) 1997-06-25
US5538949A (en) 1996-07-23
CN1088216A (zh) 1994-06-22
ATE151777T1 (de) 1997-05-15
US5935928A (en) 1999-08-10
AU665114B2 (en) 1995-12-14
CZ195193A3 (en) 1994-04-13
GR3023356T3 (en) 1997-08-29
FI934183A7 (fi) 1994-03-26
EP0589719A1 (en) 1994-03-30
MY109158A (en) 1996-12-31
FI934183A0 (fi) 1993-09-24
ZA936925B (en) 1995-03-20
US5512550A (en) 1996-04-30
MX9305901A (es) 1994-05-31
KR940007059A (ko) 1994-04-26
DK0589719T3 (da) 1997-09-08
AU4757393A (en) 1994-03-31
HUT69928A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
JP6472142B2 (ja) Ｈｃ−ｈａ／ｐｔｘ３複合体を含む組成物およびその使用方法
NO933423L (no) Modifisert blodplate-faktor-4
López-Pedrera et al. Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome
CA2388770A1 (en) Platelet aggregation inhibitors
NO20081654L (no) Stabiliserte GLP-1-analoger
Lecomte-Raclet et al. New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides
MX2021004188A (es) Composiciones polipeptídicas estabilizadas con enlace disulfuro y métodos de uso.
Mosher Labeling of a major fibroblast surface protein (fibronectin) catalyzed by blood coagulation factor XIIIa
WO2003057820A3 (en) Peptide activators of vegf
HUP9900979A2 (hu) Endoteliális sejtek proliferációját gátló inhibitor és eljárás alkalmazására
de Groot et al. Role of von Willebrand factor in the vessel wall
DE69330352D1 (de) Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
DE69737766D1 (de) Zusammensetzungen von stammzellfaktor (scf)-analogen und auf diese bezogene verfahren
Pellerin et al. Corticotropin-induced secreted protein, an ACTH-induced protein secreted by adrenocortical cells, is structurally related to thrombospondins.
ATE449790T1 (de) Rekombinante gelatinepartikel für die zelladhäsion
Lyons-Giordano et al. The effect of heparin on fibronectin and thrombospondin synthesis by human smooth muscle cells
ATE204478T1 (de) Inhibierung von leukozytenadhäsion
Moczar et al. Structural glycoprotein from the media of pig aorta. Aggregation of the S-carboxamidomethyl subunits
JP2009536821A (ja) 新規血栓溶解分子及びその製造法
Slager et al. Organization of non-muscle myosin during early murine embryonic differentiation
RU93054511A (ru) Тромбоцитарные факторы, фармацевтическая композиция, способ получения тромбоцитарных факторов, днк, вектор, клетка
Wang et al. Plants as a valuable source of bioactive peptides
ATE390481T1 (de) Modifizierte tridegine, ihre herstellung und verwendung als transglutaminase-inhibitoren
WO2024030898A3 (en) Compositions and methods for evaluating microtubule dynamics
Wagner et al. A correlative anatomic study of degenerative occlusive disease of the arteries of the lower extremities